Clearside biomedical, inc. (CLSD)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Jun'15
License and other revenue

4,097

1,942

141

45

45

-

-

-

-

-

155

130

-

-

-

-

-

-

-

License and collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

5

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

5

-

-

-

505

-

0

Operating expenses:
Research and development

3,811

1,305

2,728

658

10,967

17,486

20,083

17,343

13,379

13,935

16,050

11,478

7,590

6,971

3,682

4,213

4,589

2,309

2,147

General and administrative

3,122

3,650

3,781

5,004

4,384

4,176

3,873

3,561

3,074

2,441

2,298

2,290

2,671

2,391

1,629

970

1,273

1,065

3,023

Total operating expenses

6,933

4,955

6,509

5,662

15,351

21,662

23,956

20,904

16,453

16,376

18,348

13,768

10,261

9,362

5,311

5,183

5,862

3,374

5,170

Loss from operations

-2,836

-3,013

-6,368

-5,617

-15,306

-21,632

-23,956

-20,904

-16,453

-16,321

-18,193

-13,638

-10,256

-9,357

-5,306

-5,178

-5,357

-3,374

-5,170

Other expense

-75

-83

-168

-117

-98

-6

84

203

-154

-172

-143

-135

-117

-329

-339

76

-92

-101

-67

Net loss

-2,911

-3,096

-6,536

-5,734

-15,404

-21,638

-23,872

-20,701

-16,607

-16,493

-18,336

-13,773

-10,373

-9,686

-5,645

-5,102

-5,449

-3,475

-5,237

Net loss per share of common stock — basic and diluted

-0.07

-0.04

-0.17

-0.15

-0.45

-0.67

-0.75

-0.65

-0.62

-0.66

-0.72

-0.54

-0.41

0.98

-0.28

-0.62

-2.05

-1.31

-2.36

Weighted average shares outstanding — basic and diluted

44,753

42,488

38,414

37,636

34,144

32,112

32,024

31,979

26,818

25,347

25,338

25,309

25,250

21,046

20,493

8,243

2,660

2,651

2,216

Net loss

-2,911

-3,096

-6,536

-5,734

-15,404

-21,638

-23,872

-20,701

-16,607

-16,493

-18,336

-13,773

-10,373

-9,686

-5,645

-5,102

-5,449

-3,475

-5,237

Unrealized gain on available-for-sale investments

-

-

-

-

-

-

-

-

-

0

15

-2

-8

-

-5

-

-

-

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-16,493

-18,321

-13,775

-10,381

-9,694

-5,650

-5,102

-5,449

-3,475

-